Tenofovir Based HAART is Associated with High Rates of HBV DNA Suppression and HBEAG Seroconversion in Thai HIV-HBV Coinfected Patients by Gail Matthews given during the 20th Annual ASHM Conference powered by - MULTIWEBCAST

20th Annual ASHM Conference

LIST OF PRESENTATIONS

ABOUT THIS COURSE

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

Gail Matthews

Australia

Biography

Get HIV CME credits for this presentation!

Tenofovir Based HAART is Associated with High Rates of HBV DNA Suppression and HBEAG Seroconversion in Thai HIV-HBV Coinfected Patients

English

2008-09-20

15 slide(s)

After viewing this presentation, the participant will be able to discuss:
• The effect of tenofovir-based HAART on HBV DNA Suppression and Hepatitis ‘e’ antigen (HBEAG) Seroconversion in Thai HIV/HBV co-infected patients.

SYSTEM REQUIREMENTS
Adobe Flash Player is required in order to view the modules and complete the accredited course. If you cannot start a module please click here to download and install the current version of the Flash Player.

Disclaimer ^{AMENDED ON January 29, 2009} | Close This Window | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.